Please assess the completion status of the following clinical trial:

Trial Title: Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Male and female patients with a diagnosis of CAP and all criteria listed below:~1. Age 18 or above, no upper age limit will be employed.~2. Patients must require hospitalisation.~3. Clinical presentation of an acute illness with one or more of the following symptoms:~   1. Temperature ≥ 38.0 ⁰C (100.4°F)~  2. Dyspnoea~  3. Cough (with or without expectoration of sputum)~  4. Chest pain~  5. Malaise or fatigue~  6. Myalgia~  7. Gastro-intestinal symptoms~  8. Rales, rhonchi or wheezing~  9. Egophony or bronchial breath sounds~4. New consolidation(s) on the chest radiograph.~5. Written informed consent obtained.~6. (Pre-event) Life expectancy \> 30 days~Exclusion Criteria:~Subjects presenting with any of the following will not be included in the study:~1. (Severe) immunosuppression (e.g. HIV infection, chemotherapy, use of immunosuppressants).~2. Active neoplastic disease.~3. Obstruction pneumonia (e.g. from lung cancer).~4. Aspiration pneumonia.~5. Pneumonia that developed within 8 days after hospital discharge.~6. Unable and/or unlikely to comprehend and/or follow the protocol.~7. Pregnant and/or lactating women.~8. Other infection that requires treatment with antibiotics

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Common clinical practice (Type: ACTIVE_COMPARATOR): Treatment according to current guidelines. Often a 7 day course of antibiotics. Initial treatment should be broad spectrum antibiotics and can be narrowed down if a specific pathogen is identified.
- CRP-guided treatment (Type: EXPERIMENTAL): Treatment according to CRP levels. Patients will be started on broad spectrum antibiotics for at least 3 days, treatment can be switched to small-spectrum antibiotics if a specific pathogen is identified. From day 4 to 7 daily blood tests will be performed in order to evaluate whether or not treatment can be discontinued. If treatment is discontinued, no more blood tests will be performed.
- PCT guided treatment (Type: EXPERIMENTAL): Treatment according to PCT levels. Patients will be started on broad spectrum antibiotics for at least 3 days, treatment can be switched to small-spectrum antibiotics if a specific pathogen is identified. From day 4 to 7 daily blood tests will be performed in order to evaluate whether or not treatment can be discontinued. If treatment is discontinued, no more blood tests will be performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).